ALZHEIMERS DISEASE RESEARCH FOUNDATION: Form 990, tax year 2017
View the entire original 990 at ProPublica ↗
- Organization
- ALZHEIMERS DISEASE RESEARCH FOUNDATION (EIN 52-2396428)
- Tax period
- 2017-01-01 to 2017-12-31
- Filed
- 2018-05-01
- IRS object ID
- 201831219349300108
- Schema version
- 2017v2.2
- Source
- Download XML · Original 990 at ProPublica
Every field in the e-filed return. Faint text is the IRS element name, for citing.
- Return header
- Form 990
- Schedule A
- Schedule B
- Schedule C
- Schedule D
- Schedule F
- Schedule I
- Schedule J
- Schedule M
- Schedule O
Return header ReturnHeader
| Field | Value | IRS element (for citing) |
|---|---|---|
| Return | 2018-05-01T09:35:57-05:00 | ReturnTs |
| Tax Period End | 2017-12-31 | TaxPeriodEndDt |
Preparer Firm PreparerFirmGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Preparer Firm EIN | 042088368 | PreparerFirmEIN |
Preparer Firm Name PreparerFirmName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | GRAY GRAY & GRAY LLP | BusinessNameLine1Txt |
Preparer US Address PreparerUSAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | 150 ROYALL STREET SUITE 102 | AddressLine1Txt |
| City | CANTON | CityNm |
| State Abbreviation | MA | StateAbbreviationCd |
| ZIP | 02021 | ZIPCd |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Return Type | 990 | ReturnTypeCd |
| Tax Period Begin | 2017-01-01 | TaxPeriodBeginDt |
Filer Filer
| Field | Value | IRS element (for citing) |
|---|---|---|
| EIN | 522396428 | EIN |
Business Name BusinessName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | ALZHEIMER'S DISEASE RESEARCH FOUNDATION | BusinessNameLine1Txt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Control | ALZH | BusinessNameControlTxt |
| Phone | 7812373800 | PhoneNum |
US Address USAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | 34 WASHINGTON ST NO 200 | AddressLine1Txt |
| City | WELLESLEY HILLS | CityNm |
| State Abbreviation | MA | StateAbbreviationCd |
| ZIP | 02481 | ZIPCd |
Business Officer BusinessOfficerGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Person | TIMOTHY W ARMOUR | PersonNm |
| Person Title | PRESIDENT | PersonTitleTxt |
| Phone | 7812373800 | PhoneNum |
| Signature | 2018-04-23 | SignatureDt |
| Discuss With Paid Preparer | Yes (1) | DiscussWithPaidPreparerInd |
Preparer Person PreparerPersonGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Preparer Person | MICHAEL L CECERE | PreparerPersonNm |
| PTIN | P00236848 | PTIN |
| Phone | 7814070300 | PhoneNum |
| Preparation | 2018-04-23 | PreparationDt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Tax | 2017 | TaxYr |
| Build TS | 2022-09-23 18:48:47Z | BuildTS |
Form 990 IRS990
Doing Business As Name DoingBusinessAsName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | CURE ALZHEIMER'S FUND | BusinessNameLine1Txt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Principal Officer | TIMOTHY W ARMOUR | PrincipalOfficerNm |
US Address USAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | 34 WASHINGTON STREET | AddressLine1Txt |
| City | WELLESLEY HILLS | CityNm |
| State Abbreviation | MA | StateAbbreviationCd |
| ZIP | 02493 | ZIPCd |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Gross Receipts | $21,616,990 | GrossReceiptsAmt |
| Group Return For Affiliates | 0 | GroupReturnForAffiliatesInd |
| Organization501c3 | Yes (X) | Organization501c3Ind |
| Website Address | WWW.CUREALZ.ORG | WebsiteAddressTxt |
| Type Of Organization Corp | Yes (X) | TypeOfOrganizationCorpInd |
| Formation | 2004 | FormationYr |
| Legal Domicile State | PA | LegalDomicileStateCd |
| Activity Or Mission | TO FUND RESEARCH WITH THE HIGHEST PROBABILITY OF PREVENTING, SLOWING OR REVERSING ALZHEIMER'S DISEASE THROUGH VENTURE BASED PHILANTRHOPY WITH ALL ORGANIZATIONAL EXPENSES PAID BY THE BOARD, ALLOWING ALL PUBLIC CONTRIBUTIONS TO DIRECTLY FUND ALZHEIMER'S RESEARCH. | ActivityOrMissionDesc |
| Voting Members Governing Body | 9 | VotingMembersGoverningBodyCnt |
| Voting Members Independent | 7 | VotingMembersIndependentCnt |
| Total Employee | 22 | TotalEmployeeCnt |
| Total Volunteers | 68 | TotalVolunteersCnt |
| Total Gross UBI | $0 | TotalGrossUBIAmt |
| Net Unrelated Bus Txbl Incm | $0 | NetUnrelatedBusTxblIncmAmt |
| PY Contributions Grants | $16,220,862 | PYContributionsGrantsAmt |
| CY Contributions Grants | $17,501,551 | CYContributionsGrantsAmt |
| PY Program Service Revenue | $0 | PYProgramServiceRevenueAmt |
| CY Program Service Revenue | $0 | CYProgramServiceRevenueAmt |
| PY Investment Income | -$63,796 | PYInvestmentIncomeAmt |
| CY Investment Income | -$7,084 | CYInvestmentIncomeAmt |
| PY Other Revenue | $90 | PYOtherRevenueAmt |
| CY Other Revenue | $3,644 | CYOtherRevenueAmt |
| PY Total Revenue | $16,157,156 | PYTotalRevenueAmt |
| CY Total Revenue | $17,498,111 | CYTotalRevenueAmt |
| PY Grants And Similar Paid | $12,429,812 | PYGrantsAndSimilarPaidAmt |
| CY Grants And Similar Paid | $13,884,649 | CYGrantsAndSimilarPaidAmt |
| PY Benefits Paid To Members | $0 | PYBenefitsPaidToMembersAmt |
| CY Benefits Paid To Members | $0 | CYBenefitsPaidToMembersAmt |
| PY Salaries Comp Emp Bnft Paid | $1,298,940 | PYSalariesCompEmpBnftPaidAmt |
| CY Salaries Comp Emp Bnft Paid | $1,321,557 | CYSalariesCompEmpBnftPaidAmt |
| PY Total Prof Fndrsng Expns | $0 | PYTotalProfFndrsngExpnsAmt |
| CY Total Prof Fndrsng Expns | $0 | CYTotalProfFndrsngExpnsAmt |
| CY Total Fundraising Expense | $537,838 | CYTotalFundraisingExpenseAmt |
| PY Other Expenses | $2,786,682 | PYOtherExpensesAmt |
| CY Other Expenses | $3,793,348 | CYOtherExpensesAmt |
| PY Total Expenses | $16,515,434 | PYTotalExpensesAmt |
| CY Total Expenses | $18,999,554 | CYTotalExpensesAmt |
| PY Revenues Less Expenses | -$358,278 | PYRevenuesLessExpensesAmt |
| CY Revenues Less Expenses | -$1,501,443 | CYRevenuesLessExpensesAmt |
| Total Assets BOY | $12,463,210 | TotalAssetsBOYAmt |
| Total Assets EOY | $10,939,018 | TotalAssetsEOYAmt |
| Total Liabilities BOY | $563,695 | TotalLiabilitiesBOYAmt |
| Total Liabilities EOY | $530,632 | TotalLiabilitiesEOYAmt |
| Net Assets Or Fund Balances BOY | $11,899,515 | NetAssetsOrFundBalancesBOYAmt |
| Net Assets Or Fund Balances EOY | $10,408,386 | NetAssetsOrFundBalancesEOYAmt |
| Info In Schedule O Part III | Yes (X) | InfoInScheduleOPartIIIInd |
| Mission | FUND RESEARCH WITH THE HIGHEST PROBABILITY OF PREVENTING, SLOWING OR REVERSING ALZHEIMER'S DISEASE THROUGH VENTURE BASED PHILANTHROPY WITH ALL ORGANIZATIONAL EXPENSES PAID BY THE BOARD, ALLOWING ALL PUBLIC CONTRIBUTIONS TO DIRECTLY FUND ALZHEIMER'S RESEARCH. | MissionDesc |
| Significant New Program Srvc | 0 | SignificantNewProgramSrvcInd |
| Significant Change | 0 | SignificantChangeInd |
| Expense | $15,705,484 | ExpenseAmt |
| Grant | $13,884,649 | GrantAmt |
| Desc | IN 2017, CURE ALZHEIMER'S FUND SUPPORTED 68 RESEARCH PROJECTS AT 38 LEADING RESEARCH INSTITUTIONS, FOR A FUNDING TOTAL OF MORE THAN $15 MILLION. THE MAJORITY OF PROJECTS PURSUED A DEEPER UNDERSTANDING OF THE MECHANISMS OF ACTION OF THE GENES AND VARIANTS WITH THE BIGGEST IMPACT ON RISK AND TIMING OF ALZHEIMER'S DISEASE. OTHER PROJECTS PURSUED NOVEL THEORIES AND TOOLS TO ASSESS POTENTIAL AVENUES FOR PREVENTION AND TREATMENT. ADDITIONAL EXPENSES INCLUDE THE DIRECT SUPPORT OF FACILITATING GRANTS AND THEIR AWARD PROCESS. | Desc |
Prog Srvc Accom Acty2 ProgSrvcAccomActy2Grp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Expense | $1,946,644 | ExpenseAmt |
| Desc | CREATING AWARENESS TOOK THE FORM OF MAILINGS, OUTREACH, AND SUPPORT OF THIRD PARTY EVENTS DESIGNED TO RAISE AWARENESS ABOUT THE NEED OF MORE RESEARCH INTO THE ORIGINS AND PROGRESSION OF ALZHEIMER'S DISEASE. | Desc |
Prog Srvc Accom Acty3 ProgSrvcAccomActy3Grp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Expense | $58,172 | ExpenseAmt |
| Desc | CURE ALZHEIMER'S FUND SERVES AS FIDUCIARY AGENT FOR A SERIES OF INDEPENDENTLY PRODUCED VIDEOS ABOUT ALZHEIMER'S DISEASE. WITH AN EXECUTIVE PRODUCER, THE ORGANIZATION RECEIVES FUNDS FROM THE METROPOLITAN LIFE FOUNDATION, DISPENSES THEM AS APPROVED BY THE EXECUTIVE PRODUCER AND REPORTS THE FINANCIAL ACTIVITY PERIODICALLY TO THE METROPOLITAN LIFE FOUNDATION. | Desc |
Prog Srvc Accom Acty Other ProgSrvcAccomActyOtherGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Desc | CURE ALZHEIMER'S FUND SERVES AS FIDUCIARY AGENT FOR A SERIES OF INDEPENDENTLY PRODUCED VIDEOS ABOUT ALZHEIMER'S DISEASE. WITH AN EXECUTIVE PRODUCER, THE ORGANIZATION RECEIVES FUNDS FROM THE METROPOLITAN LIFE FOUNDATION, DISPENSES THEM AS APPROVED BY THE EXECUTIVE PRODUCER AND REPORTS THE FINANCIAL ACTIVITY PERIODICALLY TO THE METROPOLITAN LIFE FOUNDATION | Desc |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Program Service Expenses | $17,710,300 | TotalProgramServiceExpensesAmt |
| Described In Section501c3 | Yes (1) | DescribedInSection501c3Ind |
| Schedule B Required | Yes (1) | ScheduleBRequiredInd |
| Political Campaign Acty | 0 | PoliticalCampaignActyInd |
| Lobbying Activities | Yes (1) | LobbyingActivitiesInd |
| Subject To Proxy Tax | 0 | SubjectToProxyTaxInd |
| Donor Advised Fund | 0 | DonorAdvisedFundInd |
| Conservation Easements | 0 | ConservationEasementsInd |
| Collections Of Art | 0 | CollectionsOfArtInd |
| Credit Counseling | 0 | CreditCounselingInd |
| Temp Or Permanent Endowments | 0 | TempOrPermanentEndowmentsInd |
| Report Land Building Equipment | Yes (1) | ReportLandBuildingEquipmentInd |
| Report Investments Other Sec | 0 | ReportInvestmentsOtherSecInd |
| Report Program Related Invst | 0 | ReportProgramRelatedInvstInd |
| Report Other Assets | 0 | ReportOtherAssetsInd |
| Report Other Liabilities | Yes (1) | ReportOtherLiabilitiesInd |
| Include FIN48 Footnote | Yes (1) | IncludeFIN48FootnoteInd |
| Independent Audit Fincl Stmt | Yes (1) | IndependentAuditFinclStmtInd |
| Consolidated Audit Fincl Stmt | 0 | ConsolidatedAuditFinclStmtInd |
| School Operating | 0 | SchoolOperatingInd |
| Foreign Office | 0 | ForeignOfficeInd |
| Foreign Activities | Yes (1) | ForeignActivitiesInd |
| More Than5000 K To Org | Yes (1) | MoreThan5000KToOrgInd |
| More Than5000 K To Individuals | 0 | MoreThan5000KToIndividualsInd |
| Professional Fundraising | 0 | ProfessionalFundraisingInd |
| Fundraising Activities | 0 | FundraisingActivitiesInd |
| Gaming Activities | 0 | GamingActivitiesInd |
| Operate Hospital | 0 | OperateHospitalInd |
| Grants To Organizations | Yes (1) | GrantsToOrganizationsInd |
| Grants To Individuals | 0 | GrantsToIndividualsInd |
| Schedule J Required | Yes (1) | ScheduleJRequiredInd |
| Tax Exempt Bonds | 0 | TaxExemptBondsInd |
| Engaged In Excess Benefit Trans | 0 | EngagedInExcessBenefitTransInd |
| PY Excess Benefit Trans | 0 | PYExcessBenefitTransInd |
| Loan Outstanding | 0 | LoanOutstandingInd |
| Grant To Related Person | 0 | GrantToRelatedPersonInd |
| Business Rln With Org Mem | 0 | BusinessRlnWithOrgMemInd |
| Business Rln With Fam Mem | 0 | BusinessRlnWithFamMemInd |
| Business Rln With Officer Ent | 0 | BusinessRlnWithOfficerEntInd |
| Deductible Non Cash Contri | Yes (1) | DeductibleNonCashContriInd |
| Deductible Art Contribution | 0 | DeductibleArtContributionInd |
| Terminate Operations | 0 | TerminateOperationsInd |
| Partial Liquidation | 0 | PartialLiquidationInd |
| Disregarded Entity | 0 | DisregardedEntityInd |
| Related Entity | 0 | RelatedEntityInd |
| Related Organization Ctrl Ent | 0 | RelatedOrganizationCtrlEntInd |
| Trnsfr Exmpt Non Chrtbl Rltd Org | 0 | TrnsfrExmptNonChrtblRltdOrgInd |
| Activities Conducted Prtshp | 0 | ActivitiesConductedPrtshpInd |
| Schedule O Required | Yes (1) | ScheduleORequiredInd |
| IRP Document | 31 | IRPDocumentCnt |
| IRP Document W2 G | 0 | IRPDocumentW2GCnt |
| Backup Wthld Compliance | Yes (1) | BackupWthldComplianceInd |
| Employee | 22 | EmployeeCnt |
| Employment Tax Returns Filed | Yes (1) | EmploymentTaxReturnsFiledInd |
| Unrelated Bus Incm Over Limit | 0 | UnrelatedBusIncmOverLimitInd |
| Foreign Financial Account | 0 | ForeignFinancialAccountInd |
| Prohibited Tax Shelter Trans | 0 | ProhibitedTaxShelterTransInd |
| Taxable Party Notification | 0 | TaxablePartyNotificationInd |
| Nondeductible Contributions | 0 | NondeductibleContributionsInd |
| Quid Pro Quo Contributions | 0 | QuidProQuoContributionsInd |
| Form8282 Property Disposed Of | 0 | Form8282PropertyDisposedOfInd |
| Rcv Fnds To Pay Prsnl Bnft Cntrct | 0 | RcvFndsToPayPrsnlBnftCntrctInd |
| Pay Premiums Prsnl Bnft Cntrct | 0 | PayPremiumsPrsnlBnftCntrctInd |
| Form8899 Filedind | 0 | Form8899Filedind |
| Indoor Tanning Services | 0 | IndoorTanningServicesInd |
| Info In Schedule O Part VI | Yes (X) | InfoInScheduleOPartVIInd |
| Governing Body Voting Members | 9 | GoverningBodyVotingMembersCnt |
| Independent Voting Member | 7 | IndependentVotingMemberCnt |
| Family Or Business Rln | Yes (1) | FamilyOrBusinessRlnInd |
| Delegation Of Mgmt Duties | 0 | DelegationOfMgmtDutiesInd |
| Change To Org Documents | 0 | ChangeToOrgDocumentsInd |
| Material Diversion Or Misuse | 0 | MaterialDiversionOrMisuseInd |
| Members Or Stockholders | 0 | MembersOrStockholdersInd |
| Election Of Board Members | 0 | ElectionOfBoardMembersInd |
| Decisions Subject To Approva | 0 | DecisionsSubjectToApprovaInd |
| Minutes Of Governing Body | Yes (1) | MinutesOfGoverningBodyInd |
| Minutes Of Committees | Yes (1) | MinutesOfCommitteesInd |
| Officer Mailing Address | 0 | OfficerMailingAddressInd |
| Local Chapters | 0 | LocalChaptersInd |
| Form990 Provided To Gvrn Body | Yes (1) | Form990ProvidedToGvrnBodyInd |
| Conflict Of Interest Policy | Yes (1) | ConflictOfInterestPolicyInd |
| Annual Disclosure Covered Prsn | Yes (1) | AnnualDisclosureCoveredPrsnInd |
| Regular Monitoring Enfrc | Yes (1) | RegularMonitoringEnfrcInd |
| Whistleblower Policy | Yes (1) | WhistleblowerPolicyInd |
| Document Retention Policy | Yes (1) | DocumentRetentionPolicyInd |
| Compensation Process CEO | Yes (1) | CompensationProcessCEOInd |
| Compensation Process Other | Yes (1) | CompensationProcessOtherInd |
| Investment In Joint Venture | 0 | InvestmentInJointVentureInd |
| States Where Copy Of Return Is Fld | MA | StatesWhereCopyOfReturnIsFldCd |
| Own Website | Yes (X) | OwnWebsiteInd |
| Other Website | Yes (X) | OtherWebsiteInd |
| Upon Request | Yes (X) | UponRequestInd |
Books In Care Of Detail BooksInCareOfDetail
| Field | Value | IRS element (for citing) |
|---|---|---|
| Person | TIMOTHY W ARMOUR | PersonNm |
| Phone | 7812373800 | PhoneNum |
US Address USAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | 34 WASHINGTON STREET STE 200 | AddressLine1Txt |
| City | WELLESLEY HILLS | CityNm |
| State Abbreviation | MA | StateAbbreviationCd |
| ZIP | 02481 | ZIPCd |
Form990 Part VII Section A Form990PartVIISectionAGrp (11 entries)
| TitleTitleTxt | Average Hours Per WeekAverageHoursPerWeekRt | Individual Trustee Or DirectorIndividualTrusteeOrDirectorInd | Reportable Comp From OrgReportableCompFromOrgAmt | Reportable Comp From Rltd OrgReportableCompFromRltdOrgAmt | Other CompensationOtherCompensationAmt | OfficerOfficerInd | Key EmployeeKeyEmployeeInd |
|---|---|---|---|---|---|---|---|
| JEFFREY MORBY | |||||||
| CO-CHAIRMAN OF BOARD | 20.00 | Yes (X) | $0 | $0 | $0 | ||
| JACQUELINE MORBY | |||||||
| DIRECTOR | 5.00 | Yes (X) | $0 | $0 | $0 | ||
| HENRY MCCANCE | |||||||
| CO-CHAIRMAN OF BOARD | 5.00 | Yes (X) | $0 | $0 | $0 | ||
| PHYLLIS RAPPAPORT | |||||||
| TREASURER | 2.00 | Yes (X) | $0 | $0 | $0 | Yes (X) | |
| ROBERT GREENHILL | |||||||
| DIRECTOR | 2.00 | Yes (X) | $0 | $0 | $0 | ||
| TIMOTHY W ARMOUR | |||||||
| PRESIDENT & CEO | 40.00 | Yes (X) | $238,131 | $0 | $7,144 | Yes (X) | |
| SHERRY SHARP | |||||||
| DIRECTOR | 2.00 | Yes (X) | $0 | $0 | $0 | ||
| MARGARET SMITH | |||||||
| SECRETARY & SR VICE PRESID | 20.00 | $116,030 | $0 | $3,481 | Yes (X) | ||
| JOHN SLATTERY | |||||||
| SENIOR VICE PRESIDENT | 40.00 | $166,052 | $0 | $4,982 | Yes (X) | ||
| SALLY G ROSENFIELD | |||||||
| SENIOR VICE PRESIDENT | 40.00 | $162,745 | $0 | $13,924 | Yes (X) | ||
| BARBARA CHAMBERS | |||||||
| SENIOR ENGMT OFFICER, MARK | 40.00 | $158,854 | $0 | $13,671 | Yes (X) | ||
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Reportable Comp From Org | $841,812 | TotalReportableCompFromOrgAmt |
| Tot Reportable Comp Rltd Org | $0 | TotReportableCompRltdOrgAmt |
| Total Other Compensation | $43,202 | TotalOtherCompensationAmt |
| Indiv Rcvd Greater Than100 K | 5 | IndivRcvdGreaterThan100KCnt |
| Former Ofcr Employees Listed | 0 | FormerOfcrEmployeesListedInd |
| Total Comp Greater Than150 K | Yes (1) | TotalCompGreaterThan150KInd |
| Compensation From Other Srcs | 0 | CompensationFromOtherSrcsInd |
Contractor Compensation ContractorCompensationGrp (3 entries)
| Address Line1ContractorAddress/USAddress/AddressLine1Txt | CityContractorAddress/USAddress/CityNm | State AbbreviationContractorAddress/USAddress/StateAbbreviationCd | ZIPContractorAddress/USAddress/ZIPCd | ServicesServicesDesc | CompensationCompensationAmt |
|---|---|---|---|---|---|
| PROPER VILLIANS LLC | |||||
| 668 STONY HILL RD | YARDLEY | MA | 19067 | CREATIVE SERVICES | $236,520 |
| DAVID SHENK | |||||
| 216 ST JOHNS PLACE APT D | BROOKLYN | NY | 11217 | PROGRAM AND FUNDRAISING CONSULTING | $164,875 |
| GRYPHON CONSULTING LLC | |||||
| 21 DEAN ST | BELMONT | MA | 02478 | FINANACIAL AND MANAGEMENT CONSULTING | $149,286 |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Cntrct Rcvd Greater Than100 K | 3 | CntrctRcvdGreaterThan100KCnt |
| All Other Contributions | $17,501,551 | AllOtherContributionsAmt |
| Noncash Contributions | $4,108,217 | NoncashContributionsAmt |
| Total Contributions | $17,501,551 | TotalContributionsAmt |
Investment Income InvestmentIncomeGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | $13,021 | TotalRevenueColumnAmt |
| Exclusion | $13,021 | ExclusionAmt |
Gross Amount Sales Assets GrossAmountSalesAssetsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Securities | $4,098,774 | SecuritiesAmt |
Less Cost Oth Basis Sales Expnss LessCostOthBasisSalesExpnssGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Securities | $4,118,879 | SecuritiesAmt |
Gain Or Loss GainOrLossGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Securities | -$20,105 | SecuritiesAmt |
Net Gain Or Loss Investments NetGainOrLossInvestmentsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | -$20,105 | TotalRevenueColumnAmt |
| Related Or Exempt Func Income | -$20,105 | RelatedOrExemptFuncIncomeAmt |
Other Revenue Misc OtherRevenueMiscGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Desc | OTHER INCOME | Desc |
| Business | 900099 | BusinessCd |
| Total Revenue Column | $3,644 | TotalRevenueColumnAmt |
| Related Or Exempt Func Income | $3,644 | RelatedOrExemptFuncIncomeAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Other Revenue Total | $3,644 | OtherRevenueTotalAmt |
Total Revenue TotalRevenueGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | $17,498,111 | TotalRevenueColumnAmt |
| Related Or Exempt Func Income | -$16,461 | RelatedOrExemptFuncIncomeAmt |
| Unrelated Business Revenue | $0 | UnrelatedBusinessRevenueAmt |
| Exclusion | $13,021 | ExclusionAmt |
Grants To Domestic Orgs GrantsToDomesticOrgsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $12,852,704 | TotalAmt |
| Program Services | $12,852,704 | ProgramServicesAmt |
Foreign Grants ForeignGrantsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $1,031,945 | TotalAmt |
| Program Services | $1,031,945 | ProgramServicesAmt |
Comp Current Ofcr Directors CompCurrentOfcrDirectorsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $859,760 | TotalAmt |
| Program Services | $570,392 | ProgramServicesAmt |
| Management And General | $109,665 | ManagementAndGeneralAmt |
| Fundraising | $179,703 | FundraisingAmt |
Other Salaries And Wages OtherSalariesAndWagesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $317,981 | TotalAmt |
| Program Services | $92,552 | ProgramServicesAmt |
| Management And General | $204,377 | ManagementAndGeneralAmt |
| Fundraising | $21,052 | FundraisingAmt |
Pension Plan Contributions PensionPlanContributionsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $33,029 | TotalAmt |
| Program Services | $21,062 | ProgramServicesAmt |
| Management And General | $4,585 | ManagementAndGeneralAmt |
| Fundraising | $7,382 | FundraisingAmt |
Other Employee Benefits OtherEmployeeBenefitsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $30,357 | TotalAmt |
| Program Services | $7,044 | ProgramServicesAmt |
| Management And General | $23,313 | ManagementAndGeneralAmt |
Payroll Taxes PayrollTaxesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $80,430 | TotalAmt |
| Program Services | $49,021 | ProgramServicesAmt |
| Management And General | $14,881 | ManagementAndGeneralAmt |
| Fundraising | $16,528 | FundraisingAmt |
Fees For Services Legal FeesForServicesLegalGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $6,530 | TotalAmt |
| Management And General | $6,530 | ManagementAndGeneralAmt |
Fees For Services Accounting FeesForServicesAccountingGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $132,566 | TotalAmt |
| Management And General | $132,566 | ManagementAndGeneralAmt |
Fees For Services Other FeesForServicesOtherGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $330,372 | TotalAmt |
| Program Services | $221,720 | ProgramServicesAmt |
| Management And General | $53,214 | ManagementAndGeneralAmt |
| Fundraising | $55,438 | FundraisingAmt |
Advertising AdvertisingGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $93,357 | TotalAmt |
| Program Services | $87,098 | ProgramServicesAmt |
| Fundraising | $6,259 | FundraisingAmt |
Office Expenses OfficeExpensesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $25,899 | TotalAmt |
| Management And General | $25,307 | ManagementAndGeneralAmt |
| Fundraising | $592 | FundraisingAmt |
Occupancy OccupancyGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $123,215 | TotalAmt |
| Program Services | $69,000 | ProgramServicesAmt |
| Management And General | $33,268 | ManagementAndGeneralAmt |
| Fundraising | $20,947 | FundraisingAmt |
Travel TravelGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $141,661 | TotalAmt |
| Program Services | $65,878 | ProgramServicesAmt |
| Management And General | $31,580 | ManagementAndGeneralAmt |
| Fundraising | $44,203 | FundraisingAmt |
Conferences Meetings ConferencesMeetingsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $8,107 | TotalAmt |
| Program Services | $8,107 | ProgramServicesAmt |
Depreciation Depletion DepreciationDepletionGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $18,342 | TotalAmt |
| Management And General | $18,342 | ManagementAndGeneralAmt |
Insurance InsuranceGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $4,752 | TotalAmt |
| Management And General | $4,752 | ManagementAndGeneralAmt |
Other Expenses OtherExpensesGrp (4 entries)
| DescDesc | TotalTotalAmt | Program ServicesProgramServicesAmt |
|---|---|---|
| RESEARCH EXPENSES | $1,820,835 | $1,820,835 |
| PUBLIC RELATIONS | $132,050 | $132,050 |
| GOVERNMENT RELATIONS | $110,065 | $110,065 |
| MARKETING MATERIALS | $103,882 | $103,882 |
All Other Expenses AllOtherExpensesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $741,715 | TotalAmt |
| Program Services | $466,945 | ProgramServicesAmt |
| Management And General | $89,036 | ManagementAndGeneralAmt |
| Fundraising | $185,734 | FundraisingAmt |
Total Functional Expenses TotalFunctionalExpensesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $18,999,554 | TotalAmt |
| Program Services | $17,710,300 | ProgramServicesAmt |
| Management And General | $751,416 | ManagementAndGeneralAmt |
| Fundraising | $537,838 | FundraisingAmt |
Cash Non Interest Bearing CashNonInterestBearingGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $2,792,710 | BOYAmt |
| EOY | $4,096,006 | EOYAmt |
Savings And Temp Cash Invst SavingsAndTempCashInvstGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $6,371,310 | BOYAmt |
| EOY | $179,386 | EOYAmt |
Accounts Receivable AccountsReceivableGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $3,097,825 | BOYAmt |
| EOY | $2,437,328 | EOYAmt |
Prepaid Expenses Defrd Charges PrepaidExpensesDefrdChargesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $141,354 | BOYAmt |
| EOY | $183,265 | EOYAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Land Bldg Equip Cost Or Other Bss | $60,997 | LandBldgEquipCostOrOtherBssAmt |
| Land Bldg Equip Accum Deprec | $18,140 | LandBldgEquipAccumDeprecAmt |
Land Bldg Equip Basis Net LandBldgEquipBasisNetGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $50,909 | BOYAmt |
| EOY | $42,857 | EOYAmt |
Investments Pub Traded Sec InvestmentsPubTradedSecGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| EOY | $3,990,040 | EOYAmt |
Other Assets Total OtherAssetsTotalGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $9,102 | BOYAmt |
| EOY | $10,136 | EOYAmt |
Total Assets TotalAssetsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $12,463,210 | BOYAmt |
| EOY | $10,939,018 | EOYAmt |
Accounts Payable Accr Expnss AccountsPayableAccrExpnssGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $260,603 | BOYAmt |
| EOY | $319,678 | EOYAmt |
Other Liabilities OtherLiabilitiesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $303,092 | BOYAmt |
| EOY | $210,954 | EOYAmt |
Total Liabilities TotalLiabilitiesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $563,695 | BOYAmt |
| EOY | $530,632 | EOYAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Organization Follows SFAS117 | Yes (X) | OrganizationFollowsSFAS117Ind |
Unrestricted Net Assets UnrestrictedNetAssetsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $8,710,240 | BOYAmt |
| EOY | $8,303,832 | EOYAmt |
Temporarily Rstr Net Assets TemporarilyRstrNetAssetsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $3,189,275 | BOYAmt |
| EOY | $2,104,554 | EOYAmt |
Total Net Assets Fund Balance TotalNetAssetsFundBalanceGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $11,899,515 | BOYAmt |
| EOY | $10,408,386 | EOYAmt |
Tot Liab Net Assets Fund Balance TotLiabNetAssetsFundBalanceGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $12,463,210 | BOYAmt |
| EOY | $10,939,018 | EOYAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Reconcilation Revenue Expnss | -$1,501,443 | ReconcilationRevenueExpnssAmt |
| Net Unrlzd Gains Losses Invst | $10,314 | NetUnrlzdGainsLossesInvstAmt |
| Other Changes In Net Assets | $0 | OtherChangesInNetAssetsAmt |
| Method Of Accounting Accrual | Yes (X) | MethodOfAccountingAccrualInd |
| Accountant Compile Or Review | 0 | AccountantCompileOrReviewInd |
| FS Audited | Yes (1) | FSAuditedInd |
FS Audited Basis FSAuditedBasisGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Separate Basis Fincl Stmt | Yes (X) | SeparateBasisFinclStmtInd |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Audit Committee | Yes (1) | AuditCommitteeInd |
| Federal Grant Audit Required | 0 | FederalGrantAuditRequiredInd |
Schedule A IRS990ScheduleA
| Field | Value | IRS element (for citing) |
|---|---|---|
| Public Organization170 | Yes (X) | PublicOrganization170Ind |
Gifts Grants Contri Rcvd170 GiftsGrantsContriRcvd170Grp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Current Tax Year Minus4 Years | $6,388,347 | CurrentTaxYearMinus4YearsAmt |
| Current Tax Year Minus3 Years | $12,640,759 | CurrentTaxYearMinus3YearsAmt |
| Current Tax Year Minus2 Years | $11,248,214 | CurrentTaxYearMinus2YearsAmt |
| Current Tax Year Minus1 Year | $16,220,862 | CurrentTaxYearMinus1YearAmt |
| Current Tax Year | $17,501,551 | CurrentTaxYearAmt |
| Total | $63,999,733 | TotalAmt |
Total Calendar Year170 TotalCalendarYear170Grp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Current Tax Year Minus4 Years | $6,388,347 | CurrentTaxYearMinus4YearsAmt |
| Current Tax Year Minus3 Years | $12,640,759 | CurrentTaxYearMinus3YearsAmt |
| Current Tax Year Minus2 Years | $11,248,214 | CurrentTaxYearMinus2YearsAmt |
| Current Tax Year Minus1 Year | $16,220,862 | CurrentTaxYearMinus1YearAmt |
| Current Tax Year | $17,501,551 | CurrentTaxYearAmt |
| Total | $63,999,733 | TotalAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Substantial Contributors Tot | $10,376,032 | SubstantialContributorsTotAmt |
| Public Support Total170 | $53,623,701 | PublicSupportTotal170Amt |
Gross Investment Income170 GrossInvestmentIncome170Grp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Current Tax Year Minus4 Years | -$15,933 | CurrentTaxYearMinus4YearsAmt |
| Current Tax Year Minus3 Years | $11,420 | CurrentTaxYearMinus3YearsAmt |
| Current Tax Year Minus2 Years | -$3,438 | CurrentTaxYearMinus2YearsAmt |
| Current Tax Year Minus1 Year | -$63,796 | CurrentTaxYearMinus1YearAmt |
| Current Tax Year | -$7,084 | CurrentTaxYearAmt |
| Total | -$78,831 | TotalAmt |
Other Income170 OtherIncome170Grp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Current Tax Year Minus4 Years | $10,000 | CurrentTaxYearMinus4YearsAmt |
| Current Tax Year Minus2 Years | $3,150 | CurrentTaxYearMinus2YearsAmt |
| Current Tax Year Minus1 Year | $90 | CurrentTaxYearMinus1YearAmt |
| Current Tax Year | $3,644 | CurrentTaxYearAmt |
| Total | $16,884 | TotalAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Support | $63,937,786 | TotalSupportAmt |
| Public Support CY170 | 0.83870 | PublicSupportCY170Pct |
| Public Support PY170 | 0.80730 | PublicSupportPY170Pct |
| Thirty Thr Pct Suprt Tests CY170 | Yes (X) | ThirtyThrPctSuprtTestsCY170Ind |
Schedule B IRS990ScheduleB
Contributor Information ContributorInformationGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Contributor | RESTRICTED | ContributorNum |
Contributor Business Name ContributorBusinessName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | RESTRICTED | BusinessNameLine1 |
Contributor US Address ContributorUSAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | RESTRICTED | AddressLine1 |
| Address Line2 | RESTRICTED | AddressLine2 |
| City | RESTRICTED | City |
| State | RESTRICTED | State |
| ZIP Code | RESTRICTED | ZIPCode |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Contributions | RESTRICTED | TotalContributionsAmt |
Schedule C IRS990ScheduleC
| Field | Value | IRS element (for citing) |
|---|---|---|
| Volunteers | 0 | VolunteersInd |
| Paid Staff Or Management | 0 | PaidStaffOrManagementInd |
| Media Advertisements | 0 | MediaAdvertisementsInd |
| Mailings Members | 0 | MailingsMembersInd |
| Publications Or Broadcast | 0 | PublicationsOrBroadcastInd |
| Grants Other Organizations | 0 | GrantsOtherOrganizationsInd |
| Direct Contact Legislators | Yes (1) | DirectContactLegislatorsInd |
| Direct Contact Legislators | $110,065 | DirectContactLegislatorsAmt |
| Rallies Demonstrations | 0 | RalliesDemonstrationsInd |
| Other Activities | 0 | OtherActivitiesInd |
| Total Lobbying Expenditures | $110,065 | TotalLobbyingExpendituresAmt |
| Not Described Section501c3 | 0 | NotDescribedSection501c3Ind |
Supplemental Information Detail SupplementalInformationDetail
| Field | Value | IRS element (for citing) |
|---|---|---|
| Form And Line Reference | PART II-B, LINE 1: | FormAndLineReferenceDesc |
| Explanation | PART II-B, LINE 1(I), OTHER LOBBYING ACTIVITIES: A REGISTERED LOBBYIST CONTACTED VARIOUS CONGRESSIONAL LEGISLATORS FOR THE PURPOSE OF ENCOURAGING INCREASED FUNDING OF ALZHEIMER'S DISEASE RESEARCH BY THE FEDERAL GOVERNMENT. | ExplanationTxt |
Schedule D IRS990ScheduleD
Leasehold Improvements LeaseholdImprovementsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Other Cost Or Other Basis | $9,939 | OtherCostOrOtherBasisAmt |
| Depreciation | $5,027 | DepreciationAmt |
| Book Value | $4,912 | BookValueAmt |
Equipment EquipmentGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Other Cost Or Other Basis | $51,058 | OtherCostOrOtherBasisAmt |
| Depreciation | $13,113 | DepreciationAmt |
| Book Value | $37,945 | BookValueAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Book Value Land Buildings | $42,857 | TotalBookValueLandBuildingsAmt |
Other Liabilities Org OtherLiabilitiesOrgGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Desc | ACCRUED EXPENSES | Desc |
| Amt | $210,954 | Amt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Liability | $210,954 | TotalLiabilityAmt |
| Footnote Text | Yes (X) | FootnoteTextInd |
| Total Rev Etc Audited Fincl Stmt | $17,512,187 | TotalRevEtcAuditedFinclStmtAmt |
| Net Unrealized Gains Invst | $10,314 | NetUnrealizedGainsInvstAmt |
| Donated Services And Use Fclts | $3,762 | DonatedServicesAndUseFcltsAmt |
| Revenue Not Reported | $14,076 | RevenueNotReportedAmt |
| Revenue Subtotal | $17,498,111 | RevenueSubtotalAmt |
| Revenue Not Reported Fincl Stmt | $0 | RevenueNotReportedFinclStmtAmt |
| Total Revenue Per Form990 | $17,498,111 | TotalRevenuePerForm990Amt |
| Tot Expns Etc Audited Fincl Stmt | $19,003,316 | TotExpnsEtcAuditedFinclStmtAmt |
| Donated Services Use Fclts | $3,762 | DonatedServicesUseFcltsAmt |
| Expenses Not Reported | $3,762 | ExpensesNotReportedAmt |
| Expenses Subtotal | $18,999,554 | ExpensesSubtotalAmt |
| Expenses Not Rpt Fincl Stmt | $0 | ExpensesNotRptFinclStmtAmt |
| Total Expenses Per Form990 | $18,999,554 | TotalExpensesPerForm990Amt |
Supplemental Information Detail SupplementalInformationDetail
| Field | Value | IRS element (for citing) |
|---|---|---|
| Form And Line Reference | PART X, LINE 2: | FormAndLineReferenceDesc |
| Explanation | CUREALZ WAS DETERMINED TO BE EXEMPT FROM FEDERAL INCOME TAX UNDER PROVISIONS OF SECTION 501(C)(3) OF THE INTERNAL REVENUE CODE OF 1986 (IRC) AND HAS BEEN CLASSIFIED AS AN ORGANIZATION THAT IS NOT A PRIVATE FOUNDATION AS DEFINED IN SECTION 509(A)(3) OF THE IRC. ACCORDINGLY, NO PROVISIONS FOR FEDERAL OR STATE INCOME TAXES ARE REQUIRED. CUREALZ IS REQUIRED TO RECOGNIZE THE FINANCIAL STATEMENT IMPACT OF A TAX POSITION WHEN IT IS MORE LIKELY THAN NOT THAT THE POSITION WILL BE SUSTAINED UPON EXAMINATION. ANY INTEREST AND PENALTIES RECOGNIZED ASSOCIATED WITH A TAX POSITION WOULD BE CLASSIFIED AS CURRENT IN CUREALZ'S FINANCIAL STATEMENTS. CURRENTLY, THE TAX YEARS ENDED DECEMBER 31, 2014, 2015, AND 2016 ARE OPEN AND SUBJECT TO EXAMINATION BY THE INTERNAL REVENUE SERVICE AND THE MASSACHUSETTS DEPARTMENT OF REVENUE. HOWEVER, CUREALZ IS NOT CURRENTLY UNDER AUDIT NOR HAS CUREALZ BEEN CONTACTED BY ANY OF THESE JURISDICTIONS. BASED ON THE EVALUATION OF CUREALZ'S TAX POSITIONS, MANAGEMENT BELIEVES ALL POSITIONS TAKEN WOULD BE UPHELD UNDER AN EXAMINATION. THEREFORE, NO PROVISION FOR THE EFFECTS OF UNCERTAIN TAX POSITIONS HAS BEEN RECORDED FOR THE YEAR ENDED DECEMBER 31, 2017. | ExplanationTxt |
Schedule F IRS990ScheduleF
| Field | Value | IRS element (for citing) |
|---|---|---|
| Grant Records Maintained | 0 | GrantRecordsMaintainedInd |
Account Activities Outside US AccountActivitiesOutsideUSGrp (3 entries)
| RegionRegionTxt | Type Of Activities ConductedTypeOfActivitiesConductedTxt | Region Total ExpendituresRegionTotalExpendituresAmt |
|---|---|---|
| EUROPE (INCLUDING ICELAND & GREENLAND) - ALBANIA, ANDORRA, AUSTRIA, BELGIUM | GRANTS AWARDED | $633,487 |
| NORTH AMERICA | GRANTS AWARDED | $248,458 |
| EAST ASIA AND THE PACIFIC | $150,000 |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Subtotal Offices | 0 | SubtotalOfficesCnt |
| Subtotal Employees | 0 | SubtotalEmployeesCnt |
| Continuation Total Office | 0 | ContinuationTotalOfficeCnt |
| Continuation Total Employee | 0 | ContinuationTotalEmployeeCnt |
| Total Office | 0 | TotalOfficeCnt |
| Total Employee | 0 | TotalEmployeeCnt |
| Subtotal Spent | $1,031,945 | SubtotalSpentAmt |
| Continuation Spent | $0 | ContinuationSpentAmt |
| Total Spent | $1,031,945 | TotalSpentAmt |
Grants To Org Outside US GrantsToOrgOutsideUSGrp (6 entries)
| RegionRegionTxt | Purpose Of GrantPurposeOfGrantTxt | Cash GrantCashGrantAmt | Manner Of Cash DisbursementMannerOfCashDisbursementTxt |
|---|---|---|---|
| EUROPE (INCLUDING ICELAND & GREENLAND) - ALBANIA, ANDORRA, AUSTRIA, BELGIUM | THERAPUTIC MODULATION OF TREM2 ACTIVITY. | $112,000 | CHECK |
| EUROPE (INCLUDING ICELAND & GREENLAND) - ALBANIA, ANDORRA, AUSTRIA, BELGIUM | GENE EXPRESSION THROUGHOUT DEVELOPMENT OF PATHOLOGY IN APPKI MICE; EFFECTS OF HUMAN TAU AND AGEING | $198,987 | CHECK |
| EUROPE (INCLUDING ICELAND & GREENLAND) - ALBANIA, ANDORRA, AUSTRIA, BELGIUM | MANDELKOW ADD-ON: TAU MISSORTING IN ALZHEIMER'S DISEASE - CAUSES AND CONSEQUENCES | $172,500 | CHECK |
| EUROPE (INCLUDING ICELAND & GREENLAND) - ALBANIA, ANDORRA, AUSTRIA, BELGIUM | DEWILDE/DE STROOPER NANOBODIES TO CROSS THE BLOOD-BRAIN BARRIER | $150,000 | CHECK |
| NORTH AMERICA | USING HUMAN BIOENGINEERED CEREBRAL VESSELS TO EXPLORE HOW NATIVE APOLIPOPROTEIN E AFFECTS CEREBROVASCULAR PROPERTIES RELEVANT TO AD | $248,458 | CHECK |
| EAST ASIA AND THE PACIFIC | $150,000 | CHECK |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Transfer To Foreign Corp | 0 | TransferToForeignCorpInd |
| Interest In Foreign Trust | 0 | InterestInForeignTrustInd |
| Foreign Corp Ownership | 0 | ForeignCorpOwnershipInd |
| Passive Foreign Investmest Co | 0 | PassiveForeignInvestmestCoInd |
| Foreign Partnership | 0 | ForeignPartnershipInd |
| Boycott Countries | 0 | BoycottCountriesInd |
Supplemental Information Detail SupplementalInformationDetail
| Field | Value | IRS element (for citing) |
|---|---|---|
| Form And Line Reference | PART I, LINE 2: | FormAndLineReferenceDesc |
| Explanation | THE CHAIR OF THE RESEARCH CONSORTIUM (RC) AND SUITABLE MEMBERS OF THE RC AND SCIENTIFIC ADVISORY BOARD (SAB) REVIEW EACH PROPOSAL FOR FIT WITH THE CUREALZ RESEARCH PORTFOLIO, SCIENTIFIC INTEGRITY, AND VALUE TO THE SEARCH FOR A CURE FOR ALZHEIMER'S. THE BOARD OF DIRECTORS OF CURE ALZHEIMER'S FUND PROVIDES A FINAL REVIEW TO ENSURE ALL PROCEDURES HAVE BEEN FOLLOWED AND THAT THE PROPOSAL FITS WITHIN THE ORGANIZATION'S MISSION TO FUND RESEARCH CONTRIBUTING TO A CURE FOR ALZHEIMER'S DISEASE. AT LEAST TWO SCIENTIFIC REVIEWERS MUST SUBMIT A POSITIVE REVIEW FOR A PROPOSAL TO BE ACCEPTED. ANY QUESTIONS OR CONCERNS ABOUT THE PROPOSAL BY ANY MEMBER OF THE RC, SAB OR EXECUTIVE COMMITTEE WILL BE RETURNED TO THE RESEARCHER FOR CLARIFICATION. SUCH QUESTIONS OR CONCERNS MAY RESULT IN MODIFICATION AND RESUBMISSION, OR, IN EXTREME CASES, REJECTION OF THE PROPOSAL. RESEARCHERS WILL BE ADVISED OF ACCEPTANCE, QUESTION, OR REJECTION. THERE IS NO "SCORE OR ASSESSMENT COMMENTARY FROM REVIEWERS; HOWEVER, SUGGESTIONS OR IDEAS FROM REVIEWERS ARE SYNTHESIZED AND PROVIDED WITHOUT ATTRIBUTION WHEN RESEARCHERS ARE NOTIFIED THAT A PROPOSAL WILL BE FUNDED. | ExplanationTxt |
Schedule I IRS990ScheduleI
| Field | Value | IRS element (for citing) |
|---|---|---|
| Grant Records Maintained | Yes (1) | GrantRecordsMaintainedInd |
Recipient Table RecipientTable (62 entries)
| Address Line1USAddress/AddressLine1Txt | CityUSAddress/CityNm | State AbbreviationUSAddress/StateAbbreviationCd | ZIPUSAddress/ZIPCd | IRC SectionIRCSectionDesc | Cash GrantCashGrantAmt | Purpose Of GrantPurposeOfGrantTxt | Address Line2USAddress/AddressLine2Txt |
|---|---|---|---|---|---|---|---|
| CARNEGIE MELLON UNIVERSITY | |||||||
| 4400 FIFTH AVE | PITTSBURGH | PA | 15213 | 501(C)(3) | $193,786 | CIRCUITS: INTERPRETING ALZHEIMER'S DISEASE-ASSOCIATED GENETIC VARIATION AT ENHANCER REGIONS | |
| BOSTON CHILDREN'S HOSPITAL | |||||||
| 300 LONGWOOD AVE | BOSTON | MA | 02115 | 501(C)(3) | $150,000 | EARLY ROLE OF MICROGLIA IN SYNAPSE LOSS IN ALZHEIMER'S DISEASE | |
| COLUMBIA UNIVERSITY | |||||||
| 710 WEST 168TH STREET 3RD FLOOR | NEW YORK | NY | 10032 | 501(C)(3) | $200,000 | INVESTIGATING THE MECHANISM OF ENTORHINAL CORTEX HYPERMETABOLISM IN APOE4 TARGETED REPLACEMENT MICE | |
| DUKE UNIVERSITY SCHOOL OF MEDICINE | |||||||
| 8 DUKE UNIVERSITY MEDICAL CENTER | DURHAM | NC | 27703 | 501(C)(3) | $152,276 | PATHWAY CROSS-TALKS ASSOCIATED WITH SEX AND RISK FOR ALZHEIMER'S DISEASE | GREENSPACE |
| BRIGHAM AND WOMEN'S HOSPITAL | |||||||
| 75 FRANCIS STREET | BOSTON | MA | 02115 | 501(C)(3) | $250,000 | THE ROLE OF APOE IN MICROGLIA REGULATION IN NEURODEGENERATION | |
| HARVARD COLLEGE | |||||||
| 677 HUNTINGTON AVE | BOSTON | MA | 02115 | 501(C)(3) | $150,000 | GOLD ACTIVATION OF THE 26S PROTEASOME FOR THE TREATMENT OF ALZHEIMER'S DISEASE | |
| HARVARD COLLEGE | |||||||
| 677 HUNTINGTON AVE | BOSTON | MA | 02115 | 501(C)(3) | $250,000 | LAN ANALYTICAL AND STATISTICAL TOOLS FOR SEQUENCE ANALYSIS FOR ALZHEIMER'S DISEASE | |
| ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | |||||||
| ONE GUSTAE L LEVY PLACE | NEW YORK | NY | 10029 | 501(C)(3) | $150,000 | VGF, A NOVEL THERAPEUTIC EFFECTOR OF ALZHEIMER'S DESEASE PATHOGENESIS AND PROGRESSION | |
| JOAN & SANFORD I WEILL MEDICAL COLLEGE OF CORNELL UNIVERSITY | |||||||
| 1300 YORK AVE | NEW YORK | NY | 10065 | 501(C)(3) | $150,000 | REGULATION OF MICROGLIAL LYSOSOME ACIDIFICATION | |
| MASSACHUSETTS GENERAL HOSPITAL | |||||||
| 125 NASHUA STREET | BOSTON | MA | 02114 | 501(C)(3) | $350,000 | CHRONIC VIRAL NEUROINFECTION MEDIATES B-AMYLOID DEPOSITION IN TRANSGENIC AD MICE | |
| MASSACHUSETTS GENERAL HOSPITAL | |||||||
| 125 NASHUA STREET | BOSTON | MA | 02114 | 501(C)(3) | $250,000 | COMPOUNDS MODULATING MICROGLIAL UPTAKE OF AMYLOID BETA AND CD33-TARGETED IMMUNOTHERAPY FOR ALZHEIMER'S DISEASE | |
| MASSACHUSETTS GENERAL HOSPITAL | |||||||
| 125 NASHUA STREET | BOSTON | MA | 02114 | 501(C)(3) | $250,000 | HIGH-THROUGHPUT DRUG SCREENING FOR ALZHEIMER'S DISEASE USING 3D HUMAN NEURAL CULTURE SYSTEMS | |
| MASSACHUSETTS INSTITUTE OF TECHNOLOGY | |||||||
| 77 MASSACHUSETTS AVE | CAMBRIDGE | MA | 021394307 | 501(C)(3) | $100,000 | EVALUATION OF BLOOD-BRAIN BARRIER (BBB) PENETRATION OF ALZHEIMER'S DRUG TARGETS AND IDENTIFICATION OF BBB INTEGRITY ENHANCERS | |
| COLUMBIA UNIVERSITY | |||||||
| 710 WEST 168TH STREET 3RD FLOOR | NEW YORK | NY | 10032 | 501(C)(3) | $320,106 | PROPAGATION OF TAUOPATHY AND UPS DYSFUNCTION IMPACT AND RESCUE WITH A UPS ACTIVATOR | |
| COLUMBIA UNIVERSITY | |||||||
| 710 WEST 168TH STREET 3RD FLOOR | NEW YORK | NY | 10032 | 501(C)(3) | $150,000 | NOVEL CHEMICAL MODULATORS FOR BACE 1-MEDIATED CLEAVAGE OF B-AMYLOID PRECURSON PROTEIN | |
| METHODIST HOSPITAL | |||||||
| PO BOX 4384 | HOUSTON | TX | 772104384 | 501(C)(3) | $150,000 | UNCOVERING THE MOLECULAR MECHANISM OF SELECTED DRUG CANDIDATES DERIVED FROM SYSTEMATIC ALZHEIMER'S DURG REPOSITIONING | |
| MASSACHUSETTS GENERAL HOSPITAL | |||||||
| 125 NASHUA STREET | BOSTON | MA | 02114 | 501(C)(3) | $250,000 | GUT MICROBIOME MEDIATED SHIFTS IN B-AMYLOID DEPOSITION IN A HUMANIZED AD MOUSE MODEL | |
| MASSACHUSETTS GENERAL HOSPITAL | |||||||
| 125 NASHUA STREET | BOSTON | MA | 02114 | 501(C)(3) | $200,000 | EXPLORING SEX DIFFERENCES IN AD PATHOGENESIS USING 3D HUMAN NON-CELL-AUTONOMOUS MODELS | |
| MASSACHUSETTS GENERAL HOSPITAL | |||||||
| 125 NASHUA STREET | BOSTON | MA | 02114 | 501(C)(3) | $100,000 | EVALUATION OF BLOOD-BRAIN BARRIER (BBB) PENETRATION OF ALZHEIMER'S DRUG TARGETS, AND IDENTIFICATION OF BBB INTEGRITY ENHANCERS | |
| MASSACHUSETTS GENERAL HOSPITAL | |||||||
| 125 NASHUA STREET | BOSTON | MA | 02114 | 501(C)(3) | $150,000 | SWIRSHI NAHRENDORF SYSTEMIC INFLAMMATORY NETWORKS IN ALZHEIMER'S DISEASE | |
| MAYO CLINIC JACKSONVILLE | |||||||
| 125 NASHUA4500 SAN PABLO ROD S | JACKSONVILLE | FL | 32224 | 501(C)(3) | $250,000 | APOE: BU YEAR | STREET |
| MASSACHUSETTS GENERAL HOSPITAL | |||||||
| 125 NASHUA STREET | BOSTON | MA | 02114 | 501(C)(3) | $1,500,000 | ALZHEIMER'S GENOME PROJECT | |
| MASSACHUSETTS GENERAL HOSPITAL | |||||||
| 125 NASHUA STREET | BOSTON | MA | 02114 | 501(C)(3) | $200,000 | GENES TO THERAPIES (G@T) CENTRALIZED RESEARCH CORE | |
| MAYO CLINIC JACKSONVILLE | |||||||
| PO BOX 414876 | BOSTON | MA | 02114 | 501(C)(3) | $200,000 | ABCA7 IN BRAIN HOMEOSTASIS AND ALZHEIMER'S DISEASE | |
| MEMORIAL SLOAN KETTERING CANCER CENTER | |||||||
| 1275 YORK AVENUE | NEW YORK | NY | 10065 | 501(C)(3) | $150,000 | BIOCHEMICAL MAPPING OF THE GSM BINDING SITE OF THE NOVEL PYRIDAZINE-DERIVED SMALL MOLECULE Y-SECRETASE MODULATORS | |
| REGENTS OF THE UNIVERSITY OF CALIFORNIA | |||||||
| 9500 GILMAN DRIVE | SAN DIEGO | CA | 92093 | 501(C)(3) | $150,000 | 1TREATING WITH GAMMA-SECRETEASE MODULATORS TO PREVENT NEURODEGENERATION IN A MOUSE MODELS OF DOWN SYNDROME | |
| REGENTS OF THE UNIVERSITY OF CALIFORNIA | |||||||
| 1400 BIOLOGICAL SCIENCES | IRVINE | CA | 92697 | 501(C)(3) | $150,000 | VALIDATION OF ENDOGENOUS HUMAN ANTIBODIES THAT ARE CORRELATED WITH AVOIDING ALZHEIMER'S DISEASE AND THEIR CORRESPONDING ANTIGENS, FOR IMMUNOTHERAPEUTIC DEVELOPMENT | |
| SALK INSTITUTE FOR BIOLOGICAL STUDIES | |||||||
| 10010 N TORREY PINES ROAD | LA JOLLA | CA | 92037 | 501(C)(3) | $150,000 | MICROGLIAL TAM RECEPTORS AS MODULATORS OF ALZHEIMER'S PATHOLOGY | |
| SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE | |||||||
| 10901 N TORREY PINES ROAD | LA JOLLA | CA | 92037 | 501(C)(3) | $150,000 | SORA ATTENUATES A TOXICITY THROUGH INTERACTIONS WITH EPHA4 | |
| MASSACHUSETTS GENERAL HOSPITAL | |||||||
| 125 NASHUA STREET | BOSTON | MA | 02114 | 501(C)(3) | $287,500 | ROLE OF ATXN1 IN REGULATING BACE1 ACTIVITY | |
| NORTHWESTERN UNIVERSITY | |||||||
| 633 CLARK STREET | EVANSTON | IL | 60208 | 501(C)(3) | $250,000 | MOLECULAR AND CELLULAR MECHANISMS OF AN ACE1 VARIANT IN ALZHEIMER'S DISEASE | |
| THE ROCKEFELLER UNIVERSITY | |||||||
| 1230 YORK AVENUE | NEW YORK | NY | 10065 | 501(C)(3) | $250,000 | IMPACT OF APOE AND SEX ON VULNERABLE NEURON-SPECIFIC FUNCTIONAL NETWORK | |
| THE ROCKEFELLER UNIVERSITY | |||||||
| 1230 YORK AVENUE | NEW YORK | NY | 10065 | 501(C)(3) | $450,000 | DISCOVERY OF CK1 ACTIVATORS FOR INDUCING THE AUTOPHAGIC DEGRADATION OF APP BETA-CTF | |
| THE TRUSTEES OF BOSTON UNIVERSITY | |||||||
| 25 BUICK STREET | BOSTON | MA | 022151301 | 501(C)(3) | $100,000 | INHIBITION OF TAU PATHOLOGY IN HUMAN NEURONS | |
| THE TRUSTEES OF BOSTON UNIVERSITY | |||||||
| 25 BUICK STREET | BOSTON | MA | 022151301 | 501(C)(3) | $100,000 | ALZHEIMER'S DISEASE STEM CELL DRUG SCREENING IN 3D | |
| THE UNIVERSITY OF CALIFORNIA SAN DIEGO | |||||||
| 9500 GILMAN DRIVE | LA JOLLA | CA | 92093 | 501(C)(3) | $250,000 | PROTEIN KINASE C IN ALZHEIMER'S DISEASE | |
| THE UNIVERSITY OF CALIFORNIA SAN DIEGO | |||||||
| 9500 GILMAN DRIVE | LA JOLLA | CA | 92093 | 501(C)(3) | $150,000 | BIOCHEMICAL MAPPING OF THE GSM BINDING SITE OF THE NOVEL PYRIDAZINE-DERIVED SMALL MOLECULE Y-SECRETASE MODULATORS | |
| THE UNIVERSITY OF CALIFORNIA SAN DIEGO | |||||||
| 9500 GILMAN DRIVE | LA JOLLA | CA | 92093 | 501(C)(3) | $125,000 | A COMBINATION OF ANTI-AB AND GROWTH FACTOR THERAPY FOR ALZHEIMER'S DISEASE | |
| UNIVERSITY OF CHICAGO | |||||||
| 947 E 58TH STREET | CHICAGO | IL | 60637 | 501(C)(3) | $250,000 | IN VITRO AND IN VIVO ANALYSIS OF APP VARIANTS | |
| UNIVERSITY OF CHICAGO | |||||||
| 947 E 58TH STREET | CHICAGO | IL | 60637 | 501(C)(3) | $175,000 | MECHANISMS BY WHICH THE GUT MICROBIOME INFLUENCES AMYLOID DEPOSITION AND NEUROINFLAMMATION IN MOUSE MODELS OF ALZHEIMER'S DISEASE | |
| NORTHWESTERN UNIVERSITY | |||||||
| 633 CLARK STREET | EVANSTON | IL | 60208 | 501(C)(3) | $250,000 | MOLECULAR AND CELLULAR MECHANISMS OF AN ACE1 VARIANT IN ALZHEIMER'S DISEASE | |
| UNIVERSITY OF NORTH CAROLINA AT CHARLOTTE | |||||||
| 9201 UNIVERSITY CITY BLVD | CHARLOTTE | NC | 282230001 | 501(C)(3) | $150,000 | A MICROFLUIDICS-BASED HUMAN BRAIN CELL 3D CULTURE SYSTEM IN ALZHEIMER'S DISEASE | |
| UNIVERSITY OF ROCHESTER | |||||||
| 601 ELMWOOD AVENUE | ROCHESTER | NY | 14642 | 501(C)(3) | $150,000 | WILL RESTORATION OF NORMAL GLYMPHATIC FUNCTION SLOW PROGRESSION OF COGNITIVE DECLINE AND AMYLOID PLAQUES IN A MURINE ALZHEIMER MODEL? | |
| UNIVERSITY OF SOUTHERN CALIFORNIA | |||||||
| 3720 FLOWER STREET | LOS ANGELES | CA | 900892821 | 501(C)(3) | $200,000 | THE ROLE OF PICALM MUTATIONS IN ALZHEIMER'S DISEASE | |
| UNIVERSITY OF SOUTHERN CALIFORNIA | |||||||
| 3720 FLOWER STREET | LOS ANGELES | CA | 900892821 | 501(C)(3) | $156,005 | INTERACTIONS AMONG TREM2, APOE AND SEX | |
| UNIVERSITY OF VIRGINIA | |||||||
| PO BOX 400195 | CHARLOTTESVILLE | VA | 229044195 | 501(C)(3) | $150,000 | THE ROLE OF MENINGEAL LYMPHATICS IN CLEANSING THE BRAIN: IMPLICATIONS FOR ALZHEIMER'S DISEASE | |
| UNIVERSITY OF VIRGINIA | |||||||
| PO BOX 400195 | CHARLOTTESVILLE | VA | 229044195 | 501(C)(3) | $190,681 | BLOOM LAZO SHARLOW: TARGETING CELL CYCLE RE-ENTRY USING 3D NEURON CULTURES | |
| WASHINGTON UNIVERSITY ST LOUIS | |||||||
| 700 ROSEDALE AVE | ST LOUIS | MO | 631121408 | 115(1) | $150,000 | MODELING NEURONAL AGING IN SPECIFIC SUBTYPES OF HUMAN NEURONS BY MICRORNA-MEDIATED NEURONAL REPROGRAMMING | |
| WASHINGTON UNIVERSITY ST LOUIS | |||||||
| 700 ROSEDALE AVE | ST LOUIS | MO | 631121408 | 115(1) | $300,000 | UNDERSTANDING THE EFFECT OF APOE ON TAU-MEDIATED NEURODEGENERATION | |
| WASHINGTON UNIVERSITY ST LOUIS | |||||||
| 700 ROSEDALE AVE | ST LOUIS | MO | 631121408 | 115(1) | $300,000 | TREM2: ROLE IN MODULATING AB AND TAU-RELATED PATHOLOGIES AND NEURODEGENERATION | |
| WHITEHEAD INSTITUTE FOR BIOMEDICAL RESEARCH | |||||||
| 9 CAMBRIDGE CENTER | CAMBRIDGE | MA | 02142 | 501(C)(3) | $150,000 | MODELING DNA METHYLATION CHANGES IN ALZHEIMER'S DISEASE USING HUMAN-INDUCED PLURIPOTENT STEM CELLS | |
| TRUSTEES OF TUFTS COLLEGE | |||||||
| 419 BOSTON AVE | MEDFORD | MA | 02155 | 501(C)(3) | $150,000 | FUNCTIONAL CHARACTERIZATION OF GGA3 MUTATIONS ASSOCIATED WITH ALZHEIMER'S DISEASE | |
| YALE UNIVERSITY | |||||||
| 333 CEDAR ST | NEW HAVEN | CT | 06510 | 501(C)(3) | $150,000 | IMPACT OF INFLAMMASOME DEACTIVATION ON ALZHEIMER'S DISEASE | |
| UNIVERSITY OF NORTH CAROLINA AT CHARLOTTE | |||||||
| 9201 UNIVERSITY CITY BLVD | CHARLOTTE | NC | 282230001 | 501(C)(3) | $2,350 | 3D HUMAN NEURAL CELL CULTURE SYSTEM - BRIDGE FUNDING | |
| UNIVERSITY OF RHODE ISLAND | |||||||
| 45 UPPER COLLEGE ROAD | KINGSTON | RI | 02881 | 501(C)(3) | $150,000 | CEREBROVASCULAR DYSFUNCTION IN AD: TARGETING THE MECHANISMS OF VASCULAR ACTIVIATION | |
| UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER | |||||||
| 5323 HARRY HINES BLVD | DALLAS | TX | 75390 | $150,000 | GENETIC TARGETS TO BLOCK TAU PROPAGATION: TEST KNOCKDOWN OF HSPG GENES IN VIVO | ||
| WASHINGTON UNIVERSITY ST LOUIS | |||||||
| 700 ROSEDALE AVE | ST LOUIS | MO | 631121408 | 501(C)(3) | $250,000 | APOE PROTEOFORMS IN HUMAN CNS AND VALIDATION OF APOE PHARMACODYNAMIC TRANSLATIONAL MARKERS | |
| WASHINGTON UNIVERSITY ST LOUIS | |||||||
| 700 ROSEDALE AVE | ST LOUIS | MO | 631121408 | 501(C)(3) | $150,000 | TARGETING REACTIVE ASTROCYTES FOR THERAPEUTIC INTERVENTION ON ALZHEIMER'S DISEASE | |
| WASHINGTON UNIVERSITY ST LOUIS | |||||||
| 700 ROSEDALE AVE | ST LOUIS | MO | 631121408 | 501(C)(3) | $150,000 | STABLE ISOTOPE LABELING & QUANTITATIVE MASS SPECTOMETRY IMAGING OF ALZHEIMER'S DISEASE PATHOLOGY IN HUMAN | |
| WASHINGTON UNIVERSITY ST LOUIS | |||||||
| 700 ROSEDALE AVE | ST LOUIS | MO | 631121408 | 501(C)(3) | $50,000 | AB KINETICS AND ENHANCING THE DIAGNOSTIC AND PROGNOSTIC CSF BIOMARKERS OF AD | |
| THE ROCKEFELLER UNIVERSITY | |||||||
| 1230 YORK AVENUE | NEW YORK | NY | 10065 | 501(C)(3) | $150,000 | STIMULATING PROTEASOME ACTIVITY FOR THE TREATMENT OF ALZHEIMER'S DISEASE | |
| THE ROCKEFELLER UNIVERSITY | |||||||
| 1230 YORK AVENUE | NEW YORK | NY | 10065 | 501(C)(3) | $150,000 | THE ROLE OF THE CONTACT SYSTEM IN ALZHEIMER'S DISEASE | |
Supplemental Information Detail SupplementalInformationDetail
| Field | Value | IRS element (for citing) |
|---|---|---|
| Form And Line Reference | PART I, LINE 2: | FormAndLineReferenceDesc |
| Explanation | THE CHAIR OF THE RESEARCH CONSORTIUM (RC) AND SUITABLE MEMBERS OF THE RC AND SCIENTIFIC ADVISORY BOARD (SAB) REVIEW EACH PROPOSAL FOR FIT WITH THE CUREALZ RESEARCH PORTFOLIO, SCIENTIFIC INTEGRITY, AND VALUE TO THE SEARCH FOR A CURE FOR ALZHEIMER'S. THE BOARD OF DIRECTORS OF CURE ALZHEIMER'S FUND PROVIDES A FINAL REVIEW TO ENSURE ALL PROCEDURES HAVE BEEN FOLLOWED AND THAT THE PROPOSAL FITS WITHIN THE ORGANIZATION'S MISSION TO FUND RESEARCH CONTRIBUTING TO A CURE FOR ALZHEIMER'S DISEASE. AT LEAST TWO SCIENTIFIC REVIEWERS MUST SUBMIT A POSITIVE REVIEW FOR A PROPOSAL TO BE ACCEPTED. ANY QUESTIONS OR CONCERNS ABOUT THE PROPOSAL BY ANY MEMBER OF THE RC, SAB OR EXECUTIVE COMMITTEE WILL BE RETURNED TO THE RESEARCHER FOR CLARIFICATION. SUCH QUESTIONS OR CONCERNS MAY RESULT IN MODIFICATION AND RESUBMISSION, OR, IN EXTREME CASES, REJECTION OF THE PROPOSAL. RESEARCHERS WILL BE ADVISED OF ACCEPTANCE, QUESTION, OR REJECTION. THERE IS NO "SCORE OR ASSESSMENT COMMENTARY FROM REVIEWERS; HOWEVER, SUGGESTIONS OR IDEAS FROM REVIEWERS ARE SYNTHESIZED AND PROVIDED WITHOUT ATTRIBUTION WHEN RESEARCHERS ARE NOTIFIED THAT A PROPOSAL WILL BE FUNDED. | ExplanationTxt |
Schedule J IRS990ScheduleJ
| Field | Value | IRS element (for citing) |
|---|---|---|
| Compensation Committee | Yes (X) | CompensationCommitteeInd |
| Board Or Committee Approval | Yes (X) | BoardOrCommitteeApprovalInd |
| Severance Payment | 0 | SeverancePaymentInd |
| Supplemental Nonqual Rtr Plan | 0 | SupplementalNonqualRtrPlanInd |
| Equity Based Comp Arrngm | 0 | EquityBasedCompArrngmInd |
| Comp Based On Revenue Of Flng Org | 0 | CompBasedOnRevenueOfFlngOrgInd |
| Comp Bsd On Rev Related Orgs | 0 | CompBsdOnRevRelatedOrgsInd |
| Comp Bsd Net Earns Flng Org | 0 | CompBsdNetEarnsFlngOrgInd |
| Comp Bsd Net Earns Rltd Orgs | 0 | CompBsdNetEarnsRltdOrgsInd |
| Any Non Fixed Payments | 0 | AnyNonFixedPaymentsInd |
| Initial Contract Exception | 0 | InitialContractExceptionInd |
Rltd Org Officer Trst Key Empl RltdOrgOfficerTrstKeyEmplGrp (4 entries)
| TitleTitleTxt | Base Compensation Filing OrgBaseCompensationFilingOrgAmt | Compensation Based On Rltd OrgsCompensationBasedOnRltdOrgsAmt | Bonus Filing OrganizationBonusFilingOrganizationAmount | Bonus Related OrganizationsBonusRelatedOrganizationsAmt | Other Compensation Filing OrgOtherCompensationFilingOrgAmt | Other Compensation Rltd OrgsOtherCompensationRltdOrgsAmt | Deferred Compensation Flng OrgDeferredCompensationFlngOrgAmt | Deferred Comp Rltd OrgsDeferredCompRltdOrgsAmt | Nontaxable Benefits Filing OrgNontaxableBenefitsFilingOrgAmt | Nontaxable Benefits Rltd OrgsNontaxableBenefitsRltdOrgsAmt | Total Compensation Filing OrgTotalCompensationFilingOrgAmt | Total Compensation Rltd OrgsTotalCompensationRltdOrgsAmt | Comp Report Prior990 Filing OrgCompReportPrior990FilingOrgAmt | Comp Report Prior990 Rltd OrgsCompReportPrior990RltdOrgsAmt |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| TIMOTHY W ARMOUR | ||||||||||||||
| PRESIDENT & CEO | $238,131 | $0 | $0 | $0 | $0 | $0 | $7,144 | $0 | $0 | $0 | $245,275 | $0 | $0 | $0 |
| JOHN SLATTERY | ||||||||||||||
| SENIOR VICE PRESIDENT | $166,052 | $0 | $0 | $0 | $0 | $0 | $4,982 | $0 | $0 | $0 | $171,034 | $0 | $0 | $0 |
| SALLY G ROSENFIELD | ||||||||||||||
| SENIOR VICE PRESIDENT | $162,745 | $0 | $0 | $0 | $0 | $0 | $4,882 | $0 | $9,042 | $0 | $176,669 | $0 | $0 | $0 |
| BARBARA CHAMBERS | ||||||||||||||
| SENIOR ENGMT OFFICER, MARK | $158,854 | $0 | $0 | $0 | $0 | $0 | $4,766 | $0 | $8,905 | $0 | $172,525 | $0 | $0 | $0 |
Supplemental Information Detail SupplementalInformationDetail
| Field | Value | IRS element (for citing) |
|---|---|---|
| Form And Line Reference | PART I, LINE 3 | FormAndLineReferenceDesc |
| Explanation | A COMPENSATION COMMITTEE REVIEWS ALL COMPENSATION ANNUALLY. | ExplanationTxt |
Schedule M IRS990ScheduleM
Securities Publicly Traded SecuritiesPubliclyTradedGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Non Cash Checkbox | Yes (X) | NonCashCheckboxInd |
| Contribution | 78 | ContributionCnt |
| Noncash Contributions Rpt F990 | $4,108,217 | NoncashContributionsRptF990Amt |
| Method Of Determining Revenues | CLOSE OF BUSINESS | MethodOfDeterminingRevenuesTxt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Any Property That Must Be Held | 0 | AnyPropertyThatMustBeHeldInd |
| Review Process Unusual NC Gifts | 0 | ReviewProcessUnusualNCGiftsInd |
| Third Parties Used | Yes (1) | ThirdPartiesUsedInd |
Supplemental Information Detail SupplementalInformationDetail
| Field | Value | IRS element (for citing) |
|---|---|---|
| Form And Line Reference | PART I, LINE 32B: | FormAndLineReferenceDesc |
| Explanation | WHEN STOCK IS RECEIVED AS A CONTRIBUTION IT IS SOLD IMMEDIATELY UPON RECEIPT OR AS SOON THEREAFTER AS IS PRACTICAL THROUGH BANK OF NEW YORK/MELLON. | ExplanationTxt |
Schedule O IRS990ScheduleO
Supplemental Information Detail SupplementalInformationDetail (5 entries)
| Form And Line ReferenceFormAndLineReferenceDesc | ExplanationExplanationTxt |
|---|---|
| FORM 990, PART VI, SECTION A, LINE 2 | JEFFREY MORBY AND JACQUELINE MORBY ARE BOTH DIRECTORS AND SPOUSES. |
| FORM 990, PART VI, SECTION B, LINE 11B | THE PRESIDENT REVIEWS THE FORM 990 AND PROVIDES COPIES TO THE DIRECTORS BEFORE APPROVING THE FORM FOR SUBMISSION. |
| FORM 990, PART VI, SECTION B, LINE 12C | THE PRESIDENT REGULARLY AND CONSISTENTLY MONITORS COMPLIANCE WITH CONFLICTS OF INTEREST BY REQUESTING THAT ALL OFFICERS, DIRECTORS, AND FOUNDERS RADIFY AN ANNUAL STATEMENT DISCLOSING ALL INTERESTS THAT MIGHT CONFLICT WITH ANY INTEREST OF THE ORGANIZATION. |
| FORM 990, PART VI, SECTION B, LINE 15 | COMPARABILITY DATA IS SUBMITTED ANNUALLY TO THE EXECUTIVE COMMITTEE FOR COMPENSATION APPROVAL FOR THE PRESIDENT AND ALL OTHER EMPLOYEES. |
| FORM 990, PART VI, SECTION C, LINE 19 | THE ORGANIZATION'S GOVERNING DOCUMENTS AND CONFLICT OF INTEREST POLICY ARE AVAILABLE UPON REQUEST. THE ORGANIZATION'S FINANCIAL STATEMENTS ARE AVAILABLE UPON REQUEST AND AT THE ORGANIZATION'S WEBSITE. |
Comments